• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Multicenter Study of Unplanned Hospital Readmissions after Transsphenoidal Surgery for Cushing's Disease.一项关于库欣病经蝶窦手术后非计划再次入院情况的多中心研究。
J Neurol Surg B Skull Base. 2024 Aug 20;86(5):562-569. doi: 10.1055/s-0044-1789193. eCollection 2025 Oct.
2
Outcomes of the Transsphenoidal Approach for ACTH-Secreting Pituitary Tumours and the Role of Postoperative ACTH in Predicting the Late Recurrence of Cushing's Disease: A Retrospective Analysis of 50 Cases.促肾上腺皮质激素分泌型垂体瘤经蝶窦手术的结果及术后促肾上腺皮质激素在预测库欣病晚期复发中的作用:50例回顾性分析
Healthcare (Basel). 2025 Jun 11;13(12):1395. doi: 10.3390/healthcare13121395.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Readmission Within 90 Days After Primary THA Is Associated With Decreased Improvement in 1-Year Patient-reported Outcome Measures and Increased Reoperation Rates.初次全髋关节置换术后90天内再次入院与患者报告的1年结局指标改善降低及再次手术率增加相关。
Clin Orthop Relat Res. 2025 Feb 27. doi: 10.1097/CORR.0000000000003429.
5
Interventions to prevent surgical site infection in adults undergoing cardiac surgery.预防接受心脏手术的成人手术部位感染的干预措施。
Cochrane Database Syst Rev. 2024 Dec 2;12(12):CD013332. doi: 10.1002/14651858.CD013332.pub2.
6
Cushing's disease: current medical therapies and molecular insights guiding future therapies.库欣病:当前的医学治疗方法及指导未来治疗的分子见解。
Neurosurg Focus. 2015 Feb;38(2):E11. doi: 10.3171/2014.10.FOCUS14700.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Community care navigation intervention for people who are at risk of unplanned hospital presentations.针对有非计划住院风险人群的社区护理导航干预。
Cochrane Database Syst Rev. 2025 Jun 5;6(6):CD014713. doi: 10.1002/14651858.CD014713.pub2.
9
High Risk of Readmission After THA Regardless of Functional Status in Patients Discharged to Skilled Nursing Facility.入住专业护理机构的患者,无论功能状态如何,全髋关节置换术后再入院风险均高。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1185-1192. doi: 10.1097/CORR.0000000000002950. Epub 2024 Jan 16.
10
Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.择期髋关节或膝关节手术患者预防出血的药物干预措施:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2024 Jan 16;1(1):CD013295. doi: 10.1002/14651858.CD013295.pub2.

本文引用的文献

1
Multicenter Registry of Adenomas of the Pituitary and Related Disorders: Initial Description of Cushing Disease Cohort, Surgical Outcomes, and Surgeon Characteristics.多中心垂体腺瘤及相关疾病注册研究:库欣病队列的初步描述、手术结果和外科医生特征。
Neurosurgery. 2024 Aug 1;95(2):372-379. doi: 10.1227/neu.0000000000002888. Epub 2024 Mar 5.
2
An institutional experience in applying quality improvement measures to pituitary surgery: clinical and resource implications.应用质量改进措施于垂体手术的机构经验:临床与资源影响。
Neurosurg Focus. 2023 Dec;55(6):E10. doi: 10.3171/2023.9.FOCUS23545.
3
The Enhanced Recovery After Surgery protocol for the perioperative management of pituitary neuroendocrine tumors/pituitary adenomas.经手术治疗的垂体神经内分泌肿瘤/垂体腺瘤患者的术后恢复加速方案。
Neurosurg Focus. 2023 Dec;55(6):E9. doi: 10.3171/2023.9.FOCUS23529.
4
30-Day Readmissions and Coordination of Care Following Endoscopic Transsphenoidal Pituitary Surgery: Experience with 409 Patients.内镜经蝶窦垂体手术后30天再入院情况及护理协调:409例患者的经验
J Neurol Surg B Skull Base. 2021 May 25;83(Suppl 2):e410-e418. doi: 10.1055/s-0041-1729980. eCollection 2022 Jun.
5
Machine Learning-Based Analysis and Prediction of Unplanned 30-Day Readmissions After Pituitary Adenoma Resection: A Multi-Institutional Retrospective Study With External Validation.基于机器学习的垂体腺瘤切除术后 30 天非计划性再入院分析和预测:一项多机构回顾性研究及外部验证。
Neurosurgery. 2022 Aug 1;91(2):263-271. doi: 10.1227/neu.0000000000001967. Epub 2022 Apr 8.
6
Prediction of Readmission and Complications After Pituitary Adenoma Resection via the National Surgical Quality Improvement Program (NSQIP) Database.通过国家外科质量改进计划(NSQIP)数据库预测垂体腺瘤切除术后的再入院率和并发症
Cureus. 2021 May 2;13(5):e14809. doi: 10.7759/cureus.14809.
7
National trends in hospital readmission following transsphenoidal surgery for pituitary lesions.全国范围内经蝶窦手术治疗垂体病变后的医院再入院趋势。
Pituitary. 2020 Apr;23(2):79-91. doi: 10.1007/s11102-019-01007-0.
8
Readmission after endoscopic transsphenoidal pituitary surgery: analysis of 584 consecutive cases.经蝶窦垂体手术术后再入院情况:584例连续病例分析
J Neurosurg. 2019 Sep 27;133(4):1242-1247. doi: 10.3171/2019.7.JNS191558. Print 2020 Oct 1.
9
Return to the Emergency Room with or without Readmission After Endoscopic Transsphenoidal Surgery in Socioeconomically Disadvantaged Patients at an Urban Medical Center.城市医疗中心社会经济地位不利患者经蝶窦内镜手术后再次入院或未再次入院返回急诊室的情况。
World Neurosurg. 2019 Apr;124:e131-e138. doi: 10.1016/j.wneu.2018.12.039. Epub 2018 Dec 20.
10
Nationwide analysis of unplanned 30-day readmissions after transsphenoidal pituitary surgery.全国范围内经蝶窦垂体手术后 30 天内非计划性再入院情况分析。
Int Forum Allergy Rhinol. 2019 Mar;9(3):322-329. doi: 10.1002/alr.22241. Epub 2018 Nov 23.

一项关于库欣病经蝶窦手术后非计划再次入院情况的多中心研究。

A Multicenter Study of Unplanned Hospital Readmissions after Transsphenoidal Surgery for Cushing's Disease.

作者信息

Pacult Mark A, Karsy Michael, Evans James J, Kim Won, Pacione Donato R, Gardner Paul A, Fernandez-Miranda Juan C, Zada Gabriel, Rennert Robert C, Silverstein Julie M, Kim Albert H, Kshettry Varun R, Chicoine Michael R, Little Andrew S

机构信息

Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States.

Department of Neurosurgery, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States.

出版信息

J Neurol Surg B Skull Base. 2024 Aug 20;86(5):562-569. doi: 10.1055/s-0044-1789193. eCollection 2025 Oct.

DOI:10.1055/s-0044-1789193
PMID:40894433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12396873/
Abstract

OBJECTIVES

Patients undergoing surgery for Cushing's disease may be more likely to be readmitted to the hospital than other patients with pituitary disorders. We investigated rates, causes, and predictors of unplanned readmission following transsphenoidal surgery for Cushing's disease to identify areas for clinical, financial, and administrative improvements.

DESIGN

Retrospective cohort study.

SETTING

Academic pituitary centers in the United States participating in a multicenter surgical outcome registry.

PARTICIPANTS

Five hundred and nineteen patients underwent transsphenoidal surgery for treatment of Cushing's disease by 26 surgeons at nine participating institutions from 2003 to 2023.

MAIN OUTCOME MEASURES

Unplanned 90-day readmission rates and causes of readmission.

RESULTS

Unplanned readmissions occurred in 57/519 patients (11.0%), with hyponatremia in 12/57 (21%), cerebrospinal fluid leak evaluation in 8/57 (14%), epistaxis in 6/57 (10%), deep vein thrombosis in 4/57 (7%), syncope in 3/57 (5%), and headache in 3/57 (5%). Factors including no tumor on initial magnetic resonance imaging, return to the operating room during the index admission, lack of early remission, and inpatient complications were associated with a greater probability of readmission on univariate analysis. However, none remained predictive on multivariate analysis.

CONCLUSION

Our results show that readmission rates after transsphenoidal surgery for Cushing's disease are comparable to previously reported rates for all pituitary-related disorders, with the most common reason being hyponatremia. High-impact clinical protocols focused on preventing delayed hyponatremia may reduce the risk of readmission. Failure to identify significant predictors of readmission, even in this large clinical dataset, underscores the challenge of identifying high-risk clinical cohorts.

摘要

目的

与其他垂体疾病患者相比,库欣病患者接受手术后再次入院的可能性可能更高。我们调查了库欣病经蝶窦手术后计划外再入院的发生率、原因及预测因素,以确定临床、财务和管理方面可改进的领域。

设计

回顾性队列研究。

地点

美国参与多中心手术结果登记的学术性垂体中心。

参与者

2003年至2023年期间,来自9个参与机构的26名外科医生为519例患者进行了经蝶窦手术治疗库欣病。

主要观察指标

计划外90天再入院率及再入院原因。

结果

519例患者中有57例(11.0%)出现计划外再入院,其中低钠血症12例(21%),脑脊液漏评估8例(14%),鼻出血6例(10%),深静脉血栓形成4例(7%),晕厥3例(5%),头痛3例(5%)。单因素分析显示,包括初始磁共振成像未发现肿瘤、在首次住院期间返回手术室、缺乏早期缓解以及住院并发症等因素与再入院概率增加相关。然而,多因素分析中无一因素仍具有预测性。

结论

我们的结果表明,库欣病经蝶窦手术后的再入院率与先前报道的所有垂体相关疾病的再入院率相当,最常见的原因是低钠血症。专注于预防迟发性低钠血症的高影响力临床方案可能会降低再入院风险。即使在这个大型临床数据集中,未能识别出再入院的显著预测因素,凸显了识别高危临床队列的挑战。